Richard Burr: “I think we would all agree that is unacceptable.”

I will work with you as aggressively as I can to get the answers to the questions that are unanswered today on infant formula.

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.

I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.